These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 14234753)

  • 41. Chelating agents used for plutonium and uranium removal in radiation emergency medicine.
    Fukuda S
    Curr Med Chem; 2005; 12(23):2765-70. PubMed ID: 16305471
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interpretation of Enhanced Fecal and Urinary Plutonium Excretion Data under a 2-y Regular DTPA Treatment Started Months after Intake.
    Grémy O; Blanchin N; Miccoli L
    Health Phys; 2021 Nov; 121(5):494-505. PubMed ID: 34591820
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Experimental removal of 144 Ce, 241 Am, 242 Cm and 238 Pu from the rat skeleton.
    Nenot JC; Morin M; Skupinski W; Lafuma J
    Health Phys; 1972 Nov; 23(5):635-40. PubMed ID: 4653386
    [No Abstract]   [Full Text] [Related]  

  • 44. [A comparative evaluation of the efficacy of different methods for the decorporation of plutonium from the respiratory organs].
    Liubchanskiĭ ER; Sokhranich AL; Sokol'nikov ME
    Radiats Biol Radioecol; 1997; 37(1):105-10. PubMed ID: 9102121
    [TBL] [Abstract][Full Text] [Related]  

  • 45. PLUTONIUM INHALATION STUDIES. V. RADIATION SYNDROME IN BEAGLES AFTER INHALATION OF PLUTONIUM DIOXIDE.
    WEST JE; BAIR WJ
    Radiat Res; 1964 Jul; 22():489-506. PubMed ID: 14158781
    [No Abstract]   [Full Text] [Related]  

  • 46. Metabolism of plutonium introduced as Tri-N-Butylphosphate complex in the rat and removal attempts by DTPA.
    Metivier H; Masse R; Lafuma J
    Health Phys; 1983 Jun; 44(6):623-34. PubMed ID: 6853185
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Decorporation of Pu/Am Actinides by Chelation Therapy: New Arguments in Favor of an Intracellular Component of DTPA Action.
    Grémy O; Laurent D; Coudert S; Griffiths NM; Miccoli L
    Radiat Res; 2016 Jun; 185(6):568-79. PubMed ID: 27195610
    [TBL] [Abstract][Full Text] [Related]  

  • 48. REVIEW OF THERAPEUTIC PROCEDURES FOR REMOVAL OF INHALED RADIOACTIVE MATERIALS.
    TOMBROPOULOS EG
    Health Phys; 1964 Dec; 10():1251-7. PubMed ID: 14244772
    [No Abstract]   [Full Text] [Related]  

  • 49. Effective dose of DTPA, spaced at 3-day intervals, in removal of skeletal plutonium. ANL-7535.
    Rosenthal MW; Russell JJ; Moretti ES; Lindenbaum A
    ANL Rep; 1968 Dec; ():65-7. PubMed ID: 5306873
    [No Abstract]   [Full Text] [Related]  

  • 50. Effective dose of DTPA, spaced at 3 day intervals, in removal of skeletal plutonium.
    Rosenthal MW; Russell JJ; Moretti ES; Lindenbaum A
    Health Phys; 1969 Jun; 16(6):806-8. PubMed ID: 5795281
    [No Abstract]   [Full Text] [Related]  

  • 51. Chelation therapy of incorporated plutonium-238 and americium-241: comparison of LICAM(C), DTPA and DFOA in rats, hamsters and mice.
    Volf V
    Int J Radiat Biol Relat Stud Phys Chem Med; 1986 Mar; 49(3):449-62. PubMed ID: 3485592
    [TBL] [Abstract][Full Text] [Related]  

  • 52. THE METABOLISM OF BIOLOGICALLY IMPORTANT RADIONUCLIDES. VIII. SOME ASPECTS OF THE PREVENTION AND TREATMENT OF EXCESSIVE INTERNAL RADIOACTIVE CONTAMINATION.
    DUNCAN KP
    Br J Radiol; 1964 Feb; 37():120-3. PubMed ID: 14120789
    [No Abstract]   [Full Text] [Related]  

  • 53. Influence of DTPA Treatment on Internal Dose Estimates.
    Davesne E; Blanchardon E; Peleau B; Correze P; Bohand S; Franck D
    Health Phys; 2016 Jun; 110(6):551-7. PubMed ID: 27115221
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Action of DTPA on hepatic plutonium. II. DTPA-induced removal of monomeric plutonium from mouse liver parenchymal cells.
    Bhattacharyya MH; Peterson DP; Lindenbaum A
    Radiat Res; 1978 Oct; 76(1):180-6. PubMed ID: 734044
    [No Abstract]   [Full Text] [Related]  

  • 55. Preferential decorporation of americium by pulmonary administration of DTPA dry powder after inhalation of aged PuO(2) containing americium in rats.
    Grémy O; Tsapis N; Chau Q; Renault D; Abram MC; Van der Meeren A
    Radiat Res; 2010 Nov; 174(5):637-44. PubMed ID: 20726717
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Progress report: plutonium removal. IV. Tissue distribution of monomeric and polymeric plutonium as modified by a chelating agent.
    SCHUBERT J; FRIED JF; ROSENTHAL MW; LINDENBAUM A
    Annu Rep Div Biol Med Res Argonne Natl Lab; 1960 Dec; ANL-6264():177-81. PubMed ID: 15445289
    [No Abstract]   [Full Text] [Related]  

  • 57. Efficacy of orally administered amphipathic polyaminocarboxylic acid chelators for the removal of plutonium and americium: comparison with injected Zn-DTPA in the rat.
    Miller SC; Liu G; Bruenger FW; Lloyd RD
    Radiat Prot Dosimetry; 2006; 118(4):412-20. PubMed ID: 16332916
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Action of DTPA on hepatic plutonium. III. Evidence for a direct chelation mechanism for DTPA-induced excretion of monomeric plutonium into rat bile.
    Bhattacharyya MH; Peterson DP
    Radiat Res; 1979 Oct; 80(1):108-15. PubMed ID: 504565
    [No Abstract]   [Full Text] [Related]  

  • 59. Metabolism and effect of monomeric and polymeric plutonium in the immature rat liver.
    Kashima M; Mahlum DD; Sikov MR
    Health Phys; 1972 Jun; 22(6):749-52. PubMed ID: 5084005
    [No Abstract]   [Full Text] [Related]  

  • 60. Essential trace metal concentrations in beagle liver and bone tissue after prolonged Zn-DTPA treatment.
    Jones CW; Mays CW; Taylor GN
    Health Phys; 1989 Feb; 56(2):223-7. PubMed ID: 2917850
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.